25 XP   0   0   10

Wellbiotec Co. Ltd.
Buy, Hold or Sell?

Let's analyse Wellbiotec together

PenkeI guess you are interested in Wellbiotec Co. Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Wellbiotec Co. Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Wellbiotec Co. Ltd.

I send you an email if I find something interesting about Wellbiotec Co. Ltd..

Quick analysis of Wellbiotec (30 sec.)










What can you expect buying and holding a share of Wellbiotec? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩734.08
Expected worth in 1 year
₩995.79
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
₩261.71
Return On Investment
49.8%

For what price can you sell your share?

Current Price per Share
₩526.00
Expected price per share
₩0 - ₩1,024
How sure are you?
50%

1. Valuation of Wellbiotec (5 min.)




Live pricePrice per Share (EOD)

₩526.00

Intrinsic Value Per Share

₩-5,417.43 - ₩-6,508.82

Total Value Per Share

₩-4,683.34 - ₩-5,774.74

2. Growth of Wellbiotec (5 min.)




Is Wellbiotec growing?

Current yearPrevious yearGrowGrow %
How rich?$46.7m$27m$6.6m19.8%

How much money is Wellbiotec making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$1.8m$487.6k35.2%
Net Profit Margin-6.9%-28.5%--

How much money comes from the company's main activities?

3. Financial Health of Wellbiotec (5 min.)




4. Comparing to competitors in the Textile Manufacturing industry (5 min.)




  Industry Rankings (Textile Manufacturing)  


Richest
#178 / 299

Most Revenue
#206 / 299

Most Profit
#228 / 299

Most Efficient
#241 / 299

What can you expect buying and holding a share of Wellbiotec? (5 min.)

Welcome investor! Wellbiotec's management wants to use your money to grow the business. In return you get a share of Wellbiotec.

What can you expect buying and holding a share of Wellbiotec?

First you should know what it really means to hold a share of Wellbiotec. And how you can make/lose money.

Speculation

The Price per Share of Wellbiotec is ₩526.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Wellbiotec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Wellbiotec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩734.08. Based on the TTM, the Book Value Change Per Share is ₩65.43 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-2.68 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Wellbiotec.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.020.0%0.000.0%0.010.0%-0.020.0%-0.010.0%
Usd Book Value Change Per Share0.110.0%0.050.0%0.000.0%0.010.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.110.0%0.050.0%0.000.0%0.010.0%0.010.0%
Usd Price Per Share1.67-1.17-1.20-1.70-1.83-
Price to Earnings Ratio-23.58--25.57--99.85--31.39--23.47-
Price-to-Total Gains Ratio14.83--18.99--142.80--104.60--114.51-
Price to Book Ratio3.24-3.10-4.22-4.54-6.21-
Price-to-Total Gains Ratio14.83--18.99--142.80--104.60--114.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3682
Number of shares2715
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (2715 shares)124.3421.12
Gains per Year (2715 shares)497.3884.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1049748708474
209959840169158
30149214810253242
40199019780338326
50248724750422410
60298429720507494
70348234690591578
80397939660676662
90447644630760746
100497449600845830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%10.023.07.025.0%12.023.08.027.9%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%15.025.00.037.5%17.026.00.039.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.043.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%15.025.00.037.5%17.026.00.039.5%

Fundamentals of Wellbiotec

About Wellbiotec Co. Ltd.

Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and specialized medicines, health functional foods, protection products, diagnosis kits, cosmeceuticals, and other products. In addition, the company is involved in the import and export , logistics, transportation consulting; rare earth minerals business; ev charger; polydeoxyribonucleotide substance extracted from semen of salmon; and food and beverages businesses. The company was founded in 1975 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-03-24 09:19:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Wellbiotec Co. Ltd..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Wellbiotec earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • A Net Profit Margin of -9.1% means that ₩-0.09 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Wellbiotec Co. Ltd.:

  • The MRQ is -9.1%. The company is making a loss. -1
  • The TTM is -6.9%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-6.9%-2.2%
TTM-6.9%YOY-28.5%+21.7%
TTM-6.9%5Y15.0%-21.9%
5Y15.0%10Y5.4%+9.6%
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%2.2%-11.3%
TTM-6.9%1.8%-8.7%
YOY-28.5%3.7%-32.2%
5Y15.0%2.1%+12.9%
10Y5.4%2.5%+2.9%
1.1.2. Return on Assets

Shows how efficient Wellbiotec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • -2.4% Return on Assets means that Wellbiotec generated ₩-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Wellbiotec Co. Ltd.:

  • The MRQ is -2.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-3.1%+0.7%
TTM-3.1%YOY-2.0%-1.1%
TTM-3.1%5Y-5.9%+2.8%
5Y-5.9%10Y-3.4%-2.6%
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.4%0.6%-3.0%
TTM-3.1%0.5%-3.6%
YOY-2.0%1.1%-3.1%
5Y-5.9%0.9%-6.8%
10Y-3.4%0.9%-4.3%
1.1.3. Return on Equity

Shows how efficient Wellbiotec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • -3.5% Return on Equity means Wellbiotec generated ₩-0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Wellbiotec Co. Ltd.:

  • The MRQ is -3.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.5%TTM-5.0%+1.5%
TTM-5.0%YOY-7.6%+2.6%
TTM-5.0%5Y-16.7%+11.7%
5Y-16.7%10Y-9.8%-6.9%
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%1.2%-4.7%
TTM-5.0%1.2%-6.2%
YOY-7.6%2.5%-10.1%
5Y-16.7%1.8%-18.5%
10Y-9.8%1.8%-11.6%

1.2. Operating Efficiency of Wellbiotec Co. Ltd..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Wellbiotec is operating .

  • Measures how much profit Wellbiotec makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Wellbiotec Co. Ltd.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.8%+1.8%
TTM-1.8%YOY1.4%-3.2%
TTM-1.8%5Y8.5%-10.3%
5Y8.5%10Y2.5%+6.1%
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.3%-4.3%
TTM-1.8%2.0%-3.8%
YOY1.4%5.1%-3.7%
5Y8.5%4.2%+4.3%
10Y2.5%3.9%-1.4%
1.2.2. Operating Ratio

Measures how efficient Wellbiotec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Textile Manufacturing industry mean).
  • An Operation Ratio of 1.97 means that the operating costs are ₩1.97 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Wellbiotec Co. Ltd.:

  • The MRQ is 1.965. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.867. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.965TTM1.867+0.098
TTM1.867YOY1.982-0.115
TTM1.8675Y2.078-0.211
5Y2.07810Y1.719+0.359
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9651.660+0.305
TTM1.8671.676+0.191
YOY1.9821.628+0.354
5Y2.0781.623+0.455
10Y1.7191.380+0.339

1.3. Liquidity of Wellbiotec Co. Ltd..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Wellbiotec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Textile Manufacturing industry mean).
  • A Current Ratio of 3.22 means the company has ₩3.22 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Wellbiotec Co. Ltd.:

  • The MRQ is 3.217. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.471. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.217TTM2.471+0.747
TTM2.471YOY1.631+0.840
TTM2.4715Y1.899+0.572
5Y1.89910Y1.192+0.707
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2171.491+1.726
TTM2.4711.469+1.002
YOY1.6311.494+0.137
5Y1.8991.521+0.378
10Y1.1921.315-0.123
1.3.2. Quick Ratio

Measures if Wellbiotec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • A Quick Ratio of 1.36 means the company can pay off ₩1.36 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Wellbiotec Co. Ltd.:

  • The MRQ is 1.364. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.317. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.364TTM1.317+0.047
TTM1.317YOY0.989+0.328
TTM1.3175Y0.933+0.384
5Y0.93310Y0.675+0.258
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3640.551+0.813
TTM1.3170.577+0.740
YOY0.9890.633+0.356
5Y0.9330.620+0.313
10Y0.6750.576+0.099

1.4. Solvency of Wellbiotec Co. Ltd..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Wellbiotec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Wellbiotec to Textile Manufacturing industry mean.
  • A Debt to Asset Ratio of 0.29 means that Wellbiotec assets are financed with 29.3% credit (debt) and the remaining percentage (100% - 29.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Wellbiotec Co. Ltd.:

  • The MRQ is 0.293. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.372. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.293TTM0.372-0.079
TTM0.372YOY0.509-0.138
TTM0.3725Y0.461-0.090
5Y0.46110Y0.459+0.002
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2930.489-0.196
TTM0.3720.487-0.115
YOY0.5090.485+0.024
5Y0.4610.502-0.041
10Y0.4590.519-0.060
1.4.2. Debt to Equity Ratio

Measures if Wellbiotec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • A Debt to Equity ratio of 41.8% means that company has ₩0.42 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Wellbiotec Co. Ltd.:

  • The MRQ is 0.418. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.616. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.418TTM0.616-0.198
TTM0.616YOY1.389-0.774
TTM0.6165Y1.105-0.489
5Y1.10510Y1.048+0.057
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4180.870-0.452
TTM0.6160.903-0.287
YOY1.3890.905+0.484
5Y1.1050.997+0.108
10Y1.0481.163-0.115

2. Market Valuation of Wellbiotec Co. Ltd.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Wellbiotec generates.

  • Above 15 is considered overpriced but always compare Wellbiotec to the Textile Manufacturing industry mean.
  • A PE ratio of -23.58 means the investor is paying ₩-23.58 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Wellbiotec Co. Ltd.:

  • The EOD is -5.210. Based on the earnings, the company is expensive. -2
  • The MRQ is -23.576. Based on the earnings, the company is expensive. -2
  • The TTM is -25.574. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.210MRQ-23.576+18.365
MRQ-23.576TTM-25.574+1.998
TTM-25.574YOY-99.847+74.274
TTM-25.5745Y-31.388+5.814
5Y-31.38810Y-23.471-7.917
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
EOD-5.2107.622-12.832
MRQ-23.5767.177-30.753
TTM-25.5747.076-32.650
YOY-99.8477.958-107.805
5Y-31.38810.526-41.914
10Y-23.47114.684-38.155
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Wellbiotec Co. Ltd.:

  • The EOD is -0.914. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.138. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.612. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.914MRQ-4.138+3.223
MRQ-4.138TTM-1.612-2.525
TTM-1.612YOY258.815-260.427
TTM-1.6125Y51.345-52.957
5Y51.34510Y7.995+43.350
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
EOD-0.9142.804-3.718
MRQ-4.1382.150-6.288
TTM-1.6121.322-2.934
YOY258.8151.143+257.672
5Y51.3450.617+50.728
10Y7.9951.083+6.912
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Wellbiotec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Textile Manufacturing industry mean).
  • A PB ratio of 3.24 means the investor is paying ₩3.24 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Wellbiotec Co. Ltd.:

  • The EOD is 0.717. Based on the equity, the company is cheap. +2
  • The MRQ is 3.242. Based on the equity, the company is fair priced.
  • The TTM is 3.101. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD0.717MRQ3.242-2.526
MRQ3.242TTM3.101+0.142
TTM3.101YOY4.222-1.121
TTM3.1015Y4.541-1.441
5Y4.54110Y6.210-1.669
Compared to industry (Textile Manufacturing)
PeriodCompanyIndustry (mean)+/- 
EOD0.7171.086-0.369
MRQ3.2421.067+2.175
TTM3.1011.017+2.084
YOY4.2221.121+3.101
5Y4.5411.035+3.506
10Y6.2101.265+4.945
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Wellbiotec Co. Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--160.48865.427+145%-2.681+102%11.113+1344%7.538+2029%
Book Value Per Share--734.085530.808+38%425.652+72%590.188+24%489.327+50%
Current Ratio--3.2172.471+30%1.631+97%1.899+69%1.192+170%
Debt To Asset Ratio--0.2930.372-21%0.509-42%0.461-36%0.459-36%
Debt To Equity Ratio--0.4180.616-32%1.389-70%1.105-62%1.048-60%
Dividend Per Share----0%-0%-0%-0%
Eps---25.238-4.475-82%11.608-317%-30.545+21%-19.252-24%
Free Cash Flow Per Share---143.799-33.302-77%45.300-417%-19.103-87%-14.721-90%
Free Cash Flow To Equity Per Share---143.79939.354-465%-46.758-67%2.055-7097%21.054-783%
Gross Profit Margin--1.0001.0000%1.0000%0.950+5%0.800+25%
Intrinsic Value_10Y_max---6508.821--------
Intrinsic Value_10Y_min---5417.426--------
Intrinsic Value_1Y_max---131.028--------
Intrinsic Value_1Y_min---128.394--------
Intrinsic Value_3Y_max---790.901--------
Intrinsic Value_3Y_min---747.041--------
Intrinsic Value_5Y_max---1929.667--------
Intrinsic Value_5Y_min---1756.879--------
Market Cap47825392800.000-352%216396266380.000151341001195.000+43%156273562500.000+38%220751466239.000-2%237690383819.500-9%
Net Profit Margin---0.091-0.069-24%-0.285+214%0.150-161%0.054-269%
Operating Margin----0.0180%0.014-100%0.085-100%0.025-100%
Operating Ratio--1.9651.867+5%1.982-1%2.078-5%1.719+14%
Pb Ratio0.717-352%3.2423.101+5%4.222-23%4.541-29%6.210-48%
Pe Ratio-5.210+78%-23.576-25.574+8%-99.847+324%-31.388+33%-23.4710%
Price Per Share526.000-352%2380.0001664.500+43%1718.750+38%2427.900-2%2614.200-9%
Price To Free Cash Flow Ratio-0.914+78%-4.138-1.612-61%258.815-102%51.345-108%7.995-152%
Price To Total Gains Ratio3.278-352%14.830-18.994+228%-142.799+1063%-104.602+805%-114.514+872%
Quick Ratio--1.3641.317+4%0.989+38%0.933+46%0.675+102%
Return On Assets---0.024-0.031+28%-0.020-19%-0.059+144%-0.034+39%
Return On Equity---0.035-0.050+43%-0.076+119%-0.167+381%-0.098+182%
Total Gains Per Share--160.48865.427+145%-2.681+102%11.113+1344%7.538+2029%
Usd Book Value--46721537.14233783801.212+38%27091003.028+72%37563079.752+24%31143656.828+50%
Usd Book Value Change Per Share--0.1120.046+145%-0.002+102%0.008+1344%0.005+2029%
Usd Book Value Per Share--0.5140.372+38%0.298+72%0.413+24%0.343+50%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.018-0.003-82%0.008-317%-0.021+21%-0.013-24%
Usd Free Cash Flow---9152218.649-2119528.847-77%2883191.063-417%-1215830.841-87%-772950.399-92%
Usd Free Cash Flow Per Share---0.101-0.023-77%0.032-417%-0.013-87%-0.010-90%
Usd Free Cash Flow To Equity Per Share---0.1010.028-465%-0.033-67%0.001-7097%0.015-783%
Usd Market Cap33477774.960-352%151477386.466105938700.837+43%109391493.750+38%154526026.367-2%166383268.674-9%
Usd Price Per Share0.368-352%1.6661.165+43%1.203+38%1.700-2%1.830-9%
Usd Profit---1606294.543-1385946.492-14%-1873552.646+17%-3840351.876+139%-2173457.345+35%
Usd Revenue--17648731.58318812754.179-6%29960963.554-41%18713245.743-6%17810906.717-1%
Usd Total Gains Per Share--0.1120.046+145%-0.002+102%0.008+1344%0.005+2029%
 EOD+2 -6MRQTTM+18 -14YOY+21 -125Y+22 -1210Y+20 -14

3.2. Fundamental Score

Let's check the fundamental score of Wellbiotec Co. Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.210
Price to Book Ratio (EOD)Between0-10.717
Net Profit Margin (MRQ)Greater than0-0.091
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.364
Current Ratio (MRQ)Greater than13.217
Debt to Asset Ratio (MRQ)Less than10.293
Debt to Equity Ratio (MRQ)Less than10.418
Return on Equity (MRQ)Greater than0.15-0.035
Return on Assets (MRQ)Greater than0.05-0.024
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Wellbiotec Co. Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5016.658
Ma 20Greater thanMa 50813.900
Ma 50Greater thanMa 100917.160
Ma 100Greater thanMa 2001,124.480
OpenGreater thanClose550.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Selling General Administrative  5,033,509-4,585,611447,898675,2011,123,0983,683,6984,806,796-6,156,594-1,349,798



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets94,406,987
Total Liabilities27,661,934
Total Stockholder Equity66,194,176
 As reported
Total Liabilities 27,661,934
Total Stockholder Equity+ 66,194,176
Total Assets = 94,406,987

Assets

Total Assets94,406,987
Total Current Assets79,918,509
Long-term Assets14,488,478
Total Current Assets
Cash And Cash Equivalents 20,283,673
Short-term Investments 17,518,550
Net Receivables 16,360,728
Inventory 1,824,090
Other Current Assets 10,363,358
Total Current Assets  (as reported)79,918,509
Total Current Assets  (calculated)66,350,399
+/- 13,568,110
Long-term Assets
Property Plant Equipment 4,193,245
Goodwill 2,942,294
Intangible Assets 1,045,191
Long-term Assets  (as reported)14,488,478
Long-term Assets  (calculated)8,180,730
+/- 6,307,747

Liabilities & Shareholders' Equity

Total Current Liabilities24,839,284
Long-term Liabilities2,822,650
Total Stockholder Equity66,194,176
Total Current Liabilities
Short Long Term Debt 9,777,654
Other Current Liabilities 938,277
Total Current Liabilities  (as reported)24,839,284
Total Current Liabilities  (calculated)10,715,931
+/- 14,123,353
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,936,278
Long-term Liabilities  (as reported)2,822,650
Long-term Liabilities  (calculated)2,936,278
+/- 113,628
Total Stockholder Equity
Total Stockholder Equity (as reported)66,194,176
Total Stockholder Equity (calculated)0
+/- 66,194,176
Other
Capital Stock45,461,704
Common Stock Shares Outstanding 90,923
Net Invested Capital 76,016,830
Net Working Capital 55,079,225
Property Plant and Equipment Gross 5,850,211



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
62,878,180
64,387,816
63,046,462
61,228,213
61,999,260
58,404,224
69,806,733
61,253,425
62,906,135
64,103,180
64,816,467
59,088,348
58,587,127
60,744,636
58,621,087
59,864,700
58,345,395
61,312,899
61,427,526
87,006,465
84,072,132
77,481,840
106,787,815
111,157,697
115,130,219
122,786,326
127,794,144
119,823,956
124,490,502
108,340,424
101,288,021
70,920,912
92,624,306
129,310,783
126,320,883
136,826,786
72,883,909
72,731,107
67,142,773
60,207,813
68,149,299
80,890,717
94,406,987
94,406,98780,890,71768,149,29960,207,81367,142,77372,731,10772,883,909136,826,786126,320,883129,310,78392,624,30670,920,912101,288,021108,340,424124,490,502119,823,956127,794,144122,786,326115,130,219111,157,697106,787,81577,481,84084,072,13287,006,46561,427,52661,312,89958,345,39559,864,70058,621,08760,744,63658,587,12759,088,34864,816,46764,103,18062,906,13561,253,42569,806,73358,404,22461,999,26061,228,21363,046,46264,387,81662,878,180
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,845,199
39,452,701
41,803,822
41,523,479
45,911,914
43,929,088
41,491,698
70,765,063
67,321,994
87,727,438
85,324,354
82,797,624
62,523,192
61,379,961
45,937,593
39,305,204
29,629,424
31,128,565
80,489,032
78,163,243
43,795,195
56,010,366
58,023,949
52,812,036
47,853,938
55,749,772
68,334,927
79,918,509
79,918,50968,334,92755,749,77247,853,93852,812,03658,023,94956,010,36643,795,19578,163,24380,489,03231,128,56529,629,42439,305,20445,937,59361,379,96162,523,19282,797,62485,324,35487,727,43867,321,99470,765,06341,491,69843,929,08845,911,91441,523,47941,803,82239,452,70140,845,199000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,078,356
2,655,596
2,761,685
2,598,521
8,508,636
3,929,791
3,935,463
16,381,708
18,495,199
26,148,234
19,688,408
17,504,666
10,658,311
6,933,430
10,655,456
2,301,116
1,748,111
2,247,373
17,505,801
10,800,858
3,909,289
14,152,226
8,261,221
10,426,316
10,413,518
8,613,232
14,907,689
20,283,673
20,283,67314,907,6898,613,23210,413,51810,426,3168,261,22114,152,2263,909,28910,800,85817,505,8012,247,3731,748,1112,301,11610,655,4566,933,43010,658,31117,504,66619,688,40826,148,23418,495,19916,381,7083,935,4633,929,7918,508,6362,598,5212,761,6852,655,5963,078,356000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
818,426
880,693
20,488,650
7,522,000
15,758,128
15,376,612
14,513,017
12,760,080
8,214,438
3,293,144
8,694,294
6,552,887
5,052,887
8,754,198
6,322,051
5,064,301
3,064,301
12,702,848
7,783,160
4,262,435
16,091,450
19,943,006
17,518,550
17,518,55019,943,00616,091,4504,262,4357,783,16012,702,8483,064,3015,064,3016,322,0518,754,1985,052,8876,552,8878,694,2943,293,1448,214,43812,760,08014,513,01715,376,61215,758,1287,522,00020,488,650880,693818,42600000000000000000000
       Net Receivables 
11,223,238
12,368,088
10,627,507
11,700,495
10,560,876
10,560,905
11,619,036
11,483,021
9,386,361
10,654,998
10,313,910
10,503,863
9,327,420
9,968,030
9,580,480
9,756,273
8,285,346
10,006,992
9,958,143
10,566,775
10,346,241
14,136,410
14,892,598
18,013,294
14,458,660
17,827,264
16,563,406
20,255,311
19,541,230
21,128,455
17,699,193
13,791,562
15,452,596
26,164,568
31,964,881
25,175,232
27,522,779
25,263,218
22,982,624
20,832,178
20,680,255
20,175,236
16,360,728
16,360,72820,175,23620,680,25520,832,17822,982,62425,263,21827,522,77925,175,23231,964,88126,164,56815,452,59613,791,56217,699,19321,128,45519,541,23020,255,31116,563,40617,827,26414,458,66018,013,29414,892,59814,136,41010,346,24110,566,7759,958,14310,006,9928,285,3469,756,2739,580,4809,968,0309,327,42010,503,86310,313,91010,654,9989,386,36111,483,02111,619,03610,560,90510,560,87611,700,49510,627,50712,368,08811,223,238
       Other Current Assets 
1,424,694
1,549,706
1,619,556
1,951,721
2,106,393
2,256,297
1,578,669
1,439,239
2,508,750
1,365,439
1,719,547
2,103,714
1,542,960
1,914,265
1,152,947
2,009,822
1,733,367
1,129,104
1,638,539
1,582,491
1,688,271
1,790,219
1,556,083
785,885
1
0
1
1,170,180
5,259,185
1,337,886
3,815,263
786,077
674,981
18,239,275
19,356,241
1,610,876
2,386,769
1,664,090
3,985,151
-2,734,300
-2,439,732
10,781,041
10,363,358
10,363,35810,781,041-2,439,732-2,734,3003,985,1511,664,0902,386,7691,610,87619,356,24118,239,275674,981786,0773,815,2631,337,8865,259,1851,170,180101785,8851,556,0831,790,2191,688,2711,582,4911,638,5391,129,1041,733,3672,009,8221,152,9471,914,2651,542,9602,103,7141,719,5471,365,4392,508,7501,439,2391,578,6692,256,2972,106,3931,951,7211,619,5561,549,7061,424,694
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,402,781
37,461,972
44,996,520
47,472,627
53,282,403
54,161,027
53,741,014
40,991,487
61,195,742
48,521,751
47,857,640
14,997,528
16,573,543
14,207,158
14,030,737
12,353,875
12,399,527
12,555,790
14,488,478
14,488,47812,555,79012,399,52712,353,87514,030,73714,207,15816,573,54314,997,52847,857,64048,521,75161,195,74240,991,48753,741,01454,161,02753,282,40347,472,62744,996,52037,461,97227,402,781000000000000000000000000
       Property Plant Equipment 
6,535,696
6,295,025
5,279,131
5,126,824
4,822,702
4,456,032
13,488,839
13,521,060
13,466,461
13,880,562
14,213,321
13,800,268
13,641,894
13,617,829
14,099,241
14,541,224
15,037,285
15,119,490
15,311,621
15,358,106
5,114,796
4,843,747
5,222,536
5,325,876
7,785,089
15,622,874
15,083,014
13,329,000
13,403,195
10,924,570
10,126,750
2,404,649
2,061,095
3,205,823
2,831,923
1,872,001
1,916,948
1,502,327
1,406,405
1,756,491
1,919,021
1,950,547
4,193,245
4,193,2451,950,5471,919,0211,756,4911,406,4051,502,3271,916,9481,872,0012,831,9233,205,8232,061,0952,404,64910,126,75010,924,57013,403,19513,329,00015,083,01415,622,8747,785,0895,325,8765,222,5364,843,7475,114,79615,358,10615,311,62115,119,49015,037,28514,541,22414,099,24113,617,82913,641,89413,800,26814,213,32113,880,56213,466,46113,521,06013,488,8394,456,0324,822,7025,126,8245,279,1316,295,0256,535,696
       Goodwill 
5,836,838
5,836,838
5,836,838
5,836,838
5,836,838
5,836,838
5,836,838
0
0
0
0
0
0
0
0
0
0
0
0
1,209,915
1,209,915
1,209,915
1,209,915
6,045,365
6,045,365
7,142,926
7,142,926
12,713,870
12,713,870
11,213,871
12,321,438
5,443,087
5,443,086
17,043,575
17,084,296
3,603,664
5,131,282
3,603,664
3,603,665
2,942,294
2,942,294
2,942,294
2,942,294
2,942,2942,942,2942,942,2942,942,2943,603,6653,603,6645,131,2823,603,66417,084,29617,043,5755,443,0865,443,08712,321,43811,213,87112,713,87012,713,8707,142,9267,142,9266,045,3656,045,3651,209,9151,209,9151,209,9151,209,9150000000000005,836,8385,836,8385,836,8385,836,8385,836,8385,836,8385,836,838
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
151,002
181,002
211,002
241,002
18,011,107
27,241,059
26,259,381
26,030,640
25,383,878
3,468,172
3,880,259
12,200,858
14,379,333
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000014,379,33312,200,8583,880,2593,468,17225,383,87826,030,64026,259,38127,241,05918,011,107241,002211,002181,002151,002000000000000000
       Intangible Assets 
5,874,368
5,872,566
5,872,479
5,870,504
5,869,774
5,869,070
5,868,374
30,840
30,143
29,447
34,837
34,643
33,841
382,631
381,829
381,027
380,225
379,602
379,070
3,541,373
3,414,804
2,068,107
1,571,534
1,493,439
6,943,551
6,884,571
6,686,157
5,233,590
5,188,358
1,586,002
1,538,342
1,364,298
1,321,524
10,452,779
10,177,250
1,389,868
1,347,094
1,304,320
1,265,238
1,225,121
1,188,014
1,086,868
1,045,191
1,045,1911,086,8681,188,0141,225,1211,265,2381,304,3201,347,0941,389,86810,177,25010,452,7791,321,5241,364,2981,538,3421,586,0025,188,3585,233,5906,686,1576,884,5716,943,5511,493,4391,571,5342,068,1073,414,8043,541,373379,070379,602380,225381,027381,829382,63133,84134,64334,83729,44730,14330,8405,868,3745,869,0705,869,7745,870,5045,872,4795,872,5665,874,368
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
3,931,342
9,649,630
0
0
-1
-1
0
35,000,000
-2
-1
0
-1
0
-1
0
0
-2,114,913
-1
-1-2,114,91300-10-10-1-235,000,0000-1-1009,649,6303,931,342-1000000000000000000000000
> Total Liabilities 
25,567,436
23,900,940
23,717,151
20,539,410
19,839,761
18,373,989
28,359,953
26,132,414
27,159,606
26,838,774
27,289,126
22,515,700
21,259,936
23,842,194
24,173,803
26,006,729
26,010,425
29,398,666
29,628,617
60,156,618
57,829,211
55,845,347
60,250,645
34,755,553
24,305,687
34,149,815
41,063,428
44,187,470
49,861,595
58,308,145
53,677,781
51,430,394
65,280,702
85,196,804
82,395,973
103,519,879
39,966,771
27,099,265
24,192,929
22,410,292
31,794,629
28,737,669
27,661,934
27,661,93428,737,66931,794,62922,410,29224,192,92927,099,26539,966,771103,519,87982,395,97385,196,80465,280,70251,430,39453,677,78158,308,14549,861,59544,187,47041,063,42834,149,81524,305,68734,755,55360,250,64555,845,34757,829,21160,156,61829,628,61729,398,66626,010,42526,006,72924,173,80323,842,19421,259,93622,515,70027,289,12626,838,77427,159,60626,132,41428,359,95318,373,98919,839,76120,539,41023,717,15123,900,94025,567,436
   > Total Current Liabilities 
19,626,299
19,142,980
20,653,626
19,602,436
18,926,193
17,359,209
27,253,223
24,658,622
25,584,458
25,197,623
25,599,190
21,340,366
19,998,878
22,525,573
23,441,364
25,374,372
24,613,823
27,830,317
28,016,985
58,746,374
57,228,797
55,091,909
59,558,018
32,800,023
21,409,297
22,842,986
29,614,319
32,844,942
38,534,259
48,403,917
43,660,535
41,739,535
55,387,878
71,144,947
68,312,024
98,269,185
38,279,990
25,521,324
22,572,059
21,067,404
30,216,160
26,800,501
24,839,284
24,839,28426,800,50130,216,16021,067,40422,572,05925,521,32438,279,99098,269,18568,312,02471,144,94755,387,87841,739,53543,660,53548,403,91738,534,25932,844,94229,614,31922,842,98621,409,29732,800,02359,558,01855,091,90957,228,79758,746,37428,016,98527,830,31724,613,82325,374,37223,441,36422,525,57319,998,87821,340,36625,599,19025,197,62325,584,45824,658,62227,253,22317,359,20918,926,19319,602,43620,653,62619,142,98019,626,299
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,713,976
17,732,786
19,234,255
21,332,613
34,087,459
48,682,154
47,373,102
94,720
21,831,703
13,497,042
13,923,635
20,913,251
20,956,438
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000020,956,43820,913,25113,923,63513,497,04221,831,70394,72047,373,10248,682,15434,087,45921,332,61319,234,25517,732,78618,713,976000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,713,976
17,732,786
19,234,255
21,332,613
34,087,459
48,682,154
47,373,102
94,720
21,831,703
13,497,042
13,923,635
20,913,251
20,956,438
26,999,856
36,440,468
31,139,077
31,450,110
43,328,156
41,861,552
41,531,335
26,180,523
8,719,577
4,174,941
4,325,553
4,020,916
13,710,584
9,491,584
9,777,654
9,777,6549,491,58413,710,5844,020,9164,325,5534,174,9418,719,57726,180,52341,531,33541,861,55243,328,15631,450,11031,139,07736,440,46826,999,85620,956,43820,913,25113,923,63513,497,04221,831,70394,72047,373,10248,682,15434,087,45921,332,61319,234,25517,732,78618,713,976000000000000000
       Accounts payable 
6,805,105
6,416,474
6,195,204
6,587,627
6,210,544
5,391,722
5,335,381
4,902,839
4,903,709
6,730,620
6,785,219
3,709,729
3,825,866
4,243,456
4,079,531
3,985,225
4,695,958
6,267,659
4,413,887
5,739,137
4,324,103
5,763,932
3,905,013
4,995,945
5,395,400
4,799,617
6,124,878
6,088,169
5,710,489
6,531,918
6,077,216
5,009,205
4,506,813
0
0
7,402,871
18,207,660
8,686,246
10,668,252
9,134,963
10,047,102
0
0
0010,047,1029,134,96310,668,2528,686,24618,207,6607,402,871004,506,8135,009,2056,077,2166,531,9185,710,4896,088,1696,124,8784,799,6175,395,4004,995,9453,905,0135,763,9324,324,1035,739,1374,413,8876,267,6594,695,9583,985,2254,079,5314,243,4563,825,8663,709,7296,785,2196,730,6204,903,7094,902,8395,335,3815,391,7226,210,5446,587,6276,195,2046,416,4746,805,105
       Other Current Liabilities 
5,108,445
4,487,683
5,877,720
4,320,084
3,961,675
3,762,182
3,671,392
2,751,488
2,922,491
3,161,507
2,673,130
2,691,997
2,115,062
3,370,091
2,807,483
2,675,171
2,185,079
2,328,403
2,270,485
2,514,950
4,222,540
1,530,567
1,498,701
3,133,159
316,853
227,577
227,864
5,050,643
5,039,218
3,063,261
4,072,722
4,865,009
7,106,265
27,320,247
25,943,682
64,305,127
10,011,331
11,455,236
6,644,738
-1
0
17,308,917
938,277
938,27717,308,9170-16,644,73811,455,23610,011,33164,305,12725,943,68227,320,2477,106,2654,865,0094,072,7223,063,2615,039,2185,050,643227,864227,577316,8533,133,1591,498,7011,530,5674,222,5402,514,9502,270,4852,328,4032,185,0792,675,1712,807,4833,370,0912,115,0622,691,9972,673,1303,161,5072,922,4912,751,4883,671,3923,762,1823,961,6754,320,0845,877,7204,487,6835,108,445
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,896,390
11,306,829
11,449,109
11,342,527
11,327,336
9,904,228
10,017,245
9,690,860
9,892,823
14,051,857
14,083,949
1,692,830
1,686,781
1,577,941
1,620,870
1,342,888
1,578,469
1,937,169
2,822,650
2,822,6501,937,1691,578,4691,342,8881,620,8701,577,9411,686,7811,692,83014,083,94914,051,8579,892,8239,690,86010,017,2459,904,22811,327,33611,342,52711,449,10911,306,8292,896,390000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-18,713,976
-17,732,786
-19,234,255
-21,332,613
-34,087,459
-48,682,154
-47,373,102
-94,720
-21,831,703
-13,497,042
-3,505,409
-10,426,578
-20,956,438
0
9,803,683
9,638,764
0
0
2,371,118
0
0
0
0
815,973
0
0
0
2,936,278
2,936,278000815,97300002,371,118009,638,7649,803,6830-20,956,438-10,426,578-3,505,409-13,497,042-21,831,703-94,720-47,373,102-48,682,154-34,087,459-21,332,613-19,234,255-17,732,786-18,713,976000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
1
0
1
1
-1
0
1
1
0
1
0
-1
0
4,154
8,139
8,1394,1540-1010110-111010-100000000000000000000000000
> Total Stockholder Equity
37,067,503
40,236,164
39,076,559
40,412,655
41,880,393
39,770,144
41,194,183
34,924,285
35,543,899
37,057,978
37,320,481
36,370,423
37,127,648
36,707,790
34,259,985
33,662,668
32,141,476
31,715,980
31,607,526
25,462,166
24,912,069
20,626,582
45,632,953
74,669,468
90,342,374
87,984,223
86,276,566
76,303,387
75,441,264
50,938,711
48,616,346
18,986,381
26,837,791
43,613,552
43,423,136
32,821,529
32,410,363
45,225,958
42,371,122
37,263,277
35,871,260
51,599,939
66,194,176
66,194,17651,599,93935,871,26037,263,27742,371,12245,225,95832,410,36332,821,52943,423,13643,613,55226,837,79118,986,38148,616,34650,938,71175,441,26476,303,38786,276,56687,984,22390,342,37474,669,46845,632,95320,626,58224,912,06925,462,16631,607,52631,715,98032,141,47633,662,66834,259,98536,707,79037,127,64836,370,42337,320,48137,057,97835,543,89934,924,28541,194,18339,770,14441,880,39340,412,65539,076,55940,236,16437,067,503
   Common Stock
6,140,213
6,561,113
6,561,113
7,093,028
7,093,028
7,093,028
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
7,624,942
11,582,687
18,479,719
20,783,991
21,098,661
21,098,661
21,505,053
21,505,053
21,505,053
22,539,584
22,655,164
24,385,490
29,338,622
29,338,622
29,338,622
29,338,622
33,216,052
33,216,052
0
0
38,972,599
0
038,972,5990033,216,05233,216,05229,338,62229,338,62229,338,62229,338,62224,385,49022,655,16422,539,58421,505,05321,505,05321,505,05321,098,66121,098,66120,783,99118,479,71911,582,6877,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,624,9427,093,0287,093,0287,093,0286,561,1136,561,1136,140,213
   Retained Earnings Total Equity0000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667-667
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,249,113
2,006,914
2,140,574
2,228,415
2,281,246
2,211,772
2,130,723
2,353,596
2,574,421
2,193,062
2,841,583
3,646,341
3,879,007
4,803,367
5,096,083
5,493,497
4,917,984
5,000,772
4,738,822
5,063,733
4,477,431
4,481,128
4,649,048
4,818,820
0
0
4,879,905
0
04,879,905004,818,8204,649,0484,481,1284,477,4315,063,7334,738,8225,000,7724,917,9845,493,4975,096,0834,803,3673,879,0073,646,3412,841,5832,193,0622,574,4212,353,5962,130,7232,211,7722,281,2462,228,4152,140,5742,006,9142,249,113000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue107,501,453
Cost of Revenue-93,133,183
Gross Profit14,368,27014,368,270
 
Operating Income (+$)
Gross Profit14,368,270
Operating Expense-112,342,533
Operating Income-4,841,080-97,974,263
 
Operating Expense (+$)
Research Development-
Selling General Administrative4,178,516
Selling And Marketing Expenses-
Operating Expense112,342,5334,178,516
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-408,088
Net Interest Income-408,088
 
Pretax Income (+$)
Operating Income-4,841,080
Net Interest Income-408,088
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-7,440,771-4,841,080
EBIT - interestExpense = 0
-7,919,694
-7,919,694
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--7,440,771
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-7,440,771
Tax Provision-503,767
Net Income From Continuing Ops-7,944,538-7,944,539
Net Income-7,919,694
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-408,088
 

Technical Analysis of Wellbiotec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Wellbiotec. The general trend of Wellbiotec is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Wellbiotec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Wellbiotec Co. Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 874.00 < 889.00 < 1,024.

The bearish price targets are: .

Tweet this
Wellbiotec Co. Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Wellbiotec Co. Ltd.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Wellbiotec Co. Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Wellbiotec Co. Ltd.. The current macd is -107.8814384.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Wellbiotec price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Wellbiotec. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Wellbiotec price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Wellbiotec Co. Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartWellbiotec Co. Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Wellbiotec Co. Ltd.. The current adx is 31.28.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Wellbiotec shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Wellbiotec Co. Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Wellbiotec Co. Ltd.. The current sar is 899.67.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Wellbiotec Co. Ltd. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Wellbiotec Co. Ltd.. The current rsi is 16.66. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Wellbiotec Co. Ltd. Daily Relative Strength Index (RSI) ChartWellbiotec Co. Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Wellbiotec Co. Ltd.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Wellbiotec price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Wellbiotec Co. Ltd. Daily Stochastic Oscillator ChartWellbiotec Co. Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Wellbiotec Co. Ltd.. The current cci is -148.35227622.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Wellbiotec Co. Ltd. Daily Commodity Channel Index (CCI) ChartWellbiotec Co. Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Wellbiotec Co. Ltd.. The current cmo is -77.6689143.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Wellbiotec Co. Ltd. Daily Chande Momentum Oscillator (CMO) ChartWellbiotec Co. Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Wellbiotec Co. Ltd.. The current willr is -98.61386139.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Wellbiotec Co. Ltd. Daily Williams %R ChartWellbiotec Co. Ltd. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Wellbiotec Co. Ltd..

Wellbiotec Co. Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Wellbiotec Co. Ltd.. The current atr is 63.67.

Wellbiotec Co. Ltd. Daily Average True Range (ATR) ChartWellbiotec Co. Ltd. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Wellbiotec Co. Ltd.. The current obv is 97,892,361.

Wellbiotec Co. Ltd. Daily On-Balance Volume (OBV) ChartWellbiotec Co. Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Wellbiotec Co. Ltd.. The current mfi is 30.87.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Wellbiotec Co. Ltd. Daily Money Flow Index (MFI) ChartWellbiotec Co. Ltd. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Wellbiotec Co. Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Wellbiotec Co. Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Wellbiotec Co. Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5016.658
Ma 20Greater thanMa 50813.900
Ma 50Greater thanMa 100917.160
Ma 100Greater thanMa 2001,124.480
OpenGreater thanClose550.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Wellbiotec with someone you think should read this too:
  • Are you bullish or bearish on Wellbiotec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Wellbiotec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Wellbiotec Co. Ltd.

I send you an email if I find something interesting about Wellbiotec Co. Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Wellbiotec Co. Ltd..

Receive notifications about Wellbiotec Co. Ltd. in your mailbox!